"We seek to develop breakthrough drugs by integrating the accumulated drug discovery research outcomes of academia with those of pharmaceutical companies derived from the analytical simulation on cloud."
Tatsuhiko Kodama Professor, RCAST, The University of Tokyo
At the Research Center for Advanced Science and Technology, the University of Tokyo (RCAST) is pursuing interdisciplinary research covering key domains: information, biology, environment, material, universal-design and society. A sixth domain is biochemical medicine, and RCAST is trying to understand the mechanisms of diseases and pursuing R&D into new drugs.
Pharmaceutical companies and research institutes around the world are eager to harness cutting-edge science and technology in their quest for new drugs.
The University of Tokyo has its own supercomputer and high-performance computing (HPC) cloud environment and decided to use Fujitsu’s cloud service for analytical simulations.
Read the full RCAST, The University of Tokyo case study (615 KB/A4, 2 pages)
Bu sayfayı paylaş